🇮🇳 India Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

GPT Healthcare Limited GPTHEALTH NSEPHARMA

Healthcare · Medical Care Facilities · India
https://ilshospitals.com
Company Profile ↓
₹155.34
-3.10% 1Y
Mkt Cap₹1,274.64 Cr
P/E30.16
P/B4.76
Div. Yield1.90%
52W High₹181.88
52W Low₹115.31
Book Value₹32.84
EPS (TTM)₹5.15

Company Overview

GPT Healthcare Limited owns and operates a chain of multispecialty hospitals under the ILS Hospitals brand name in India. The company offers healthcare services, including internal medicine and diabetology; nephrology, such as renal transplants; laparoscopic and general surgery; gynecology and obstetrics; critical care; gastroenterology; orthopedics and joint replacement; interventional cardiology; neurology; neurosurgery; pediatrics; neonatology; robotic-assisted surgery; bariatric surgery; hematology; psychology; dermatology; and ENT services. It also operates clinics and pharmacies; provides academic and diagnostic services; and sale of pharmaceutical products. The company was incorporated in 1989 and is based in Kolkata, India. GPT Healthcare Limited operates as a subsidiary of GPT Sons Pvt. Ltd.

Why Investors Should Care

Strong Return on Equity

Generates a return on equity of 15.7%, reflecting efficient use of shareholder capital.

Healthy Capital Returns

Return on capital employed stands at 16.2%.

Reasonable Valuation

Trades at a P/E of 30.2, below the sector median of 40.0.

Conservative Balance Sheet

Carries low leverage with a debt-to-equity ratio of 0.34.

Positive Free Cash Flow

Generates positive free cash flow, funding growth and shareholder returns internally.

Recent Developments

  • Mar 2026 Revenue of ₹472.35 Cr (+16.5% YoY); net profit ₹42.22 Cr.
  • Trailing 12 Months Year-on-year growth — revenue +16.5%, earnings -15.4%.
  • 5-Year Trend Long-term compounding — revenue CAGR 9.6%, profit CAGR 2.7%.

Growth & Price Performance

Compounded Sales Growth

5 Years:9.65%
1 Year:16.47%

Compounded Profit Growth

5 Years:2.67%
1 Year:-15.43%

Stock Price Performance

1 Year:-3.10%
6 Months:+10.39%
3 Months:+14.87%
1 Month:+5.50%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bullish
52-Week Range 60% of range
₹115.31 ₹181.88
Trend Signals
  • Price vs 50-DMAAbove
  • Price vs 200-DMAAbove
  • RSI (14)56.71 · Neutral
Price Performance
1M+5.50%
3M+14.87%
6M+10.39%
1Y-3.10%
Valuation vs Sector

P/E of 30.16 is below the sector median of 39.97 — relatively cheaper than peers.

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

NSE TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Generates positive free cash flow.
  • In a confirmed uptrend (50-DMA above 200-DMA).

CONS

No notable concerns flagged.

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
30.16
Industry PE
39.97
Forward P/E
15.53
PEG Ratio
-
Book Value
₹32.84
Price to Book
4.76
P/S
2.72
EV/EBITDA
15.76
Dividend Yield
1.90%

Growth (CAGR)

Revenue 5Y
9.65%
Profit 5Y
2.67%
Revenue (YoY)
16.47%
Earnings (YoY)
-15.43%

Profitability & Returns

ROCE
16.18%
ROE
15.67%
ROA
9.08%
Profit Margin
8.94%
Op Margin
12.43%
Gross Margin
64.41%
EPS (Latest Qtr)
₹1.78
EPS (TTM)
₹5.15

Balance Sheet & Liquidity

Debt/Equity
0.34
Quick Ratio
0.99
Current Ratio
1.12
Debt
₹91.18 Cr
Total Assets
₹464.75 Cr
Current Assets
₹89.28 Cr
Working Capital
₹9.78 Cr

Ownership

Promoter Holding
66.77%
Chg in Prom Hold
1.20%
FII / Inst Holding
7.42%
Chg in FII Hold
-2.23%

Financial Snapshot

Enterprise Value
₹1,274.64 Cr
Total Revenue (TTM)
₹472.35 Cr
EBITDA
₹89.44 Cr
Free Cash Flow
₹39.34 Cr
Operating Cash Flow
₹81.16 Cr
Shares Outstanding
₹8.21 Cr
Gross Margin
64.41%
Payout Ratio
48.54%

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP ₹P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 GPTHEALTH GPT Healthcare Limited NSEPHARMA 155.34 30.16 ₹1,274.64 Cr 1.90% 16.18% 15.67% 9.65% 2.67%
2 SUNPHARMA Sun Pharmaceutical Industries Limited NIFTY50NSEAIPHARMA 1,948.80 40.77 ₹4.68 L Cr 0.83% 17.94% 13.74% 10.39% 10.65%
3 DIVISLAB Divi's Laboratories Limited NSEPHARMA 7,315.50 75.61 ₹1.94 L Cr 0.44% 18.96% 15.32% 11.27% 12.08%
4 TORNTPHARM Torrent Pharmaceuticals Limited NSEPHARMA 4,952.20 87.70 ₹1.68 L Cr 0.78% 9.05% 25.79% 13.27% 20.22%
5 APOLLOHOSP Apollo Hospitals Enterprise Limited NIFTY50NSEAIPHARMA 8,981.00 66.51 ₹1.29 L Cr 0.23% 19.79% 20.48% 15.33% 33.34%
6 CIPLA Cipla Limited NIFTY50NSEAIPHARMA 1,440.10 22.07 ₹1.16 L Cr 0.90% 14.86% 11.27% 7.23% 11.45%
7 ZYDUSLIFE Zydus Lifesciences Limited NSEPHARMA 1,137.40 22.71 ₹1.14 L Cr 0.09% 19.04% 18.59% 16.55% 36.99%
8 LUPIN Lupin Limited NIFTY_MIDNSEPHARMA 2,494.30 21.42 ₹1.14 L Cr 0.72% 28.42% 23.76% 19.10% 131.46%
9 MAXHEALTH Max Healthcare Institute Limited NSEAIPHARMA 1,099.00 99.82 ₹1.07 L Cr 0.18% 12.57% 13.42% 22.37% 9.34%
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in INR.

Metric Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue 101.40 Cr107.11 Cr118.91 Cr120.16 Cr126.37 Cr
Cost of Revenue 38.01 Cr41.09 Cr42.48 Cr44.96 Cr45.61 Cr
Gross Profit 63.39 Cr66.02 Cr76.42 Cr75.20 Cr80.76 Cr
Operating Expenses 47.57 Cr54.83 Cr60.53 Cr61.60 Cr64.34 Cr
Operating Income 15.82 Cr11.18 Cr15.89 Cr13.60 Cr16.42 Cr
EBITDA 22.26 Cr18.93 Cr24.08 Cr22.13 Cr25.00 Cr
Interest Expense 1.02 Cr1.63 Cr2.16 Cr2.26 Cr2.18 Cr
Pretax Income 16.37 Cr11.11 Cr15.07 Cr12.76 Cr15.86 Cr
Tax Provision 3.48 Cr3.43 Cr4.46 Cr3.39 Cr1.30 Cr
Net Income 12.89 Cr7.68 Cr10.60 Cr9.37 Cr14.57 Cr
Diluted EPS 1.570.941.291.141.78

Profit & Loss (Annual)

Figures in INR.

Metric Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue 212.00 Cr243.00 Cr-358.32 Cr398.57 Cr405.57 Cr472.35 Cr
Cost of Revenue ---133.84 Cr147.26 Cr146.95 Cr168.11 Cr
Gross Profit ---224.48 Cr251.31 Cr258.62 Cr304.24 Cr
Operating Expenses 176.00 Cr194.00 Cr-164.28 Cr178.73 Cr190.02 Cr245.55 Cr
Operating Income 25.00 Cr37.00 Cr-60.20 Cr72.58 Cr68.59 Cr58.69 Cr
EBITDA 36.00 Cr49.00 Cr-79.32 Cr92.52 Cr90.91 Cr89.44 Cr
Interest Expense 14.00 Cr14.00 Cr-8.44 Cr6.49 Cr2.53 Cr7.54 Cr
Pretax Income 15.00 Cr29.00 Cr-55.97 Cr68.04 Cr69.35 Cr54.81 Cr
Tax Provision 3.90 Cr7.83 Cr-16.96 Cr20.27 Cr19.42 Cr12.59 Cr
Net Income 11.00 Cr21.00 Cr-39.01 Cr47.77 Cr49.92 Cr42.22 Cr
Diluted EPS 6.1111.76-4.755.966.085.15

Balance Sheet (Annual)

Figures in INR.

Metric Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets 308.00 Cr317.00 Cr-326.76 Cr345.52 Cr384.25 Cr464.75 Cr
Current Assets ---81.27 Cr80.16 Cr78.82 Cr89.28 Cr
Cash & Equivalents ---6.60 Cr1.69 Cr1.66 Cr4.13 Cr
Inventory ---8.92 Cr8.15 Cr8.82 Cr10.60 Cr
Receivables ---20.68 Cr24.28 Cr19.70 Cr20.28 Cr
Total Liabilities ---161.40 Cr127.03 Cr136.40 Cr195.32 Cr
Current Liabilities ---81.84 Cr77.21 Cr74.24 Cr79.49 Cr
Long Term Debt ---40.27 Cr3.62 Cr5.53 Cr7.16 Cr
Total Debt 157.00 Cr166.00 Cr-82.36 Cr30.54 Cr35.30 Cr91.18 Cr
Total Equity 127.00 Cr134.00 Cr-165.36 Cr218.49 Cr247.85 Cr269.43 Cr
Shares Outstanding ---8.21 Cr8.21 Cr8.21 Cr8.21 Cr

Cash Flows (Annual)

Figures in INR.

Metric Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow 41.00 Cr43.00 Cr-66.36 Cr68.80 Cr67.40 Cr81.16 Cr
Investing Cash Flow -54.00 Cr-16.00 Cr-5.15 Cr-25.21 Cr-32.59 Cr-47.25 Cr
Financing Cash Flow 12.00 Cr-22.00 Cr--73.18 Cr-48.50 Cr-34.84 Cr-31.43 Cr
Capital Expenditure -46.00 Cr-5.00 Cr--9.95 Cr-19.37 Cr-49.93 Cr-41.82 Cr
Free Cash Flow -5.00 Cr38.00 Cr-56.41 Cr49.43 Cr17.47 Cr39.34 Cr
Net Change in Cash -1.00 Cr4.00 Cr--1.67 Cr-4.91 Cr-3.44 L2.47 Cr

Ratios (Annual)

Figures in %.

Metric Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Margin % ---62.6%63.1%63.8%64.4%
Operating Margin % 11.8%15.2%-16.8%18.2%16.9%12.4%
Net Margin % 5.2%8.6%-10.9%12.0%12.3%8.9%
ROE % 8.7%15.7%-23.6%21.9%20.1%15.7%
ROCE % ---24.6%27.1%22.1%15.2%

Shareholding Pattern

Insiders
66.77%
Institutions
7.42%
Public Float
22.32%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for GPTHEALTH

Google News Wed, 07 Jan 2026

Introducing ChatGPT Health - OpenAI

<a href="https://news.google.com/rss/articles/CBMiYkFVX3lxTE1NN182QVdKeERlaTBWeVNNdTlUY19MNGVZZ1VzeEVhY3FIU1d2SHRLejJpMENpbnFWclYyZTFkb2NWR21Lc1NCVkUwZXVIdGhHeUxTV3RyWkd5WnFIRnJUNFhB?oc=5" target="_blank">Introducing ChatGPT Health</a>&nbsp…

Google News hu, 08 Jan 2026

OpenAI launches ChatGPT Health to review your medical records - BBC

<a href="https://news.google.com/rss/articles/CBMiWkFVX3lxTE1IRXBCVVg5dGxtTzhsNkZiREdqcjBiQktRWFZEYi1sbVZUNDF6M19xQnVNSzFIUXBuVFlpU05FV19lcFp5a25sT0kyZ1N5MGJPUlBiby0tSTczQQ?oc=5" target="_blank">OpenAI launches ChatGPT Health to review your…

Google News Mon, 18 May 2026

GPT Healthcare Q4 Revenue Jumps 26% to ₹126 Cr Amid Margin Pressure - Sahi

<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxNWERxRjlXMlAtb2ozQlZvVE1wYXBBOHFDejFlNlNxWExNZ1QyZjNhSnA3aVFmX01Da0JFYjlELUFwTnFUV0FBbXFTRjA1cUd3UnRJZXdSUXVwZlhsOHRVNkhtb21iTll2dXBQOG0xWm5vcHdlaEd4VUpGejFMbGt1UFpFMFVTSHhjdngwT2…

Google News Sat, 02 Aug 2025

The Market Lifts GPT Healthcare Limited (NSE:GPTHEALTH) Shares 27% But It Can Do More - simplywall.st

<a href="https://news.google.com/rss/articles/CBMi2wFBVV95cUxOZmtvUE9WTlJKNzR1Q29JeDNIN2pnd0J0THEzSk4xbG5NY0JvWjZBa1RtNTVHVkRjdG1MUWMzWHBkWjIyMm5vNFF1akFPTVUxYldiQ2FzNm5GQnRGc3FvbEtsVUNVMkNlMFhxQ3dXdEx0UjhZcDNXQVphYmZ6NFRWME9jUFRvRy1vZV9oLV…

Google News Wed, 03 Jul 2024

GPTHEALTH Stock Price and Chart — NSE:GPTHEALTH - TradingView

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9ZX2Rxckd0T2RMS2tYMlluY3JRMjZSS2VQOEl3TTdmWGxaZEszekVWOWJfdVRQejZYZzJTMS0tckFndWxJbmN2TExDdTNQcllGQ1BURFFFZEE2bDhoSVlr?oc=5" target="_blank">GPTHEALTH Stock Price and Chart — NSE:G…

Google News ue, 08 Jul 2025

GPT Healthcare (NSE:GPTHEALTH) Is Paying Out A Dividend Of ₹1.50 - simplywall.st

<a href="https://news.google.com/rss/articles/CBMi2wFBVV95cUxQWTJETHc5dWxYbmVvdU1leWhlMXREVWtvUkQ5QlZfZ2hXQXUxSmk3c2I0STFZRWQ5cGFTLTBnRm81bDE5anlQLUg1ZmI3TWlRRXBkTHhZcjF6Um8yTXV2U0Fkb3FLUjNoTDZBX1hmM1BXb0U0cEJwMEZDWHE0WkZtNFFmUGpBSDNXZzdZWk…

GPTHEALTH — Frequently Asked Questions

What is the current share price of GPT Healthcare Limited (GPTHEALTH)?

As of 2026-07-15 09:52 IST, GPT Healthcare Limited (GPTHEALTH) trades at ₹155.34 on NSE. Its 52-week range is ₹115.31 to ₹181.88.

What is the market capitalisation of GPTHEALTH?

GPT Healthcare Limited (GPTHEALTH) has a market capitalisation of ₹1,274.64 Cr on NSE.

What is the P/E ratio of GPTHEALTH?

GPTHEALTH trades at a trailing price-to-earnings (P/E) ratio of 30.16. The industry average P/E is 39.97. Its price-to-book (P/B) ratio is 4.76.

Does GPTHEALTH pay a dividend?

GPT Healthcare Limited (GPTHEALTH) currently offers a dividend yield of 1.90%.

What is the return on equity (ROE) of GPTHEALTH?

GPTHEALTH has a return on equity (ROE) of 15.67%. Its return on capital employed (ROCE) is 16.18%.

Is GPTHEALTH a good stock to buy?

This page provides a data-driven analysis of GPT Healthcare Limited (GPTHEALTH), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All India Stocks
⚙Ad space